http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109745372-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-718 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-718 |
| filingDate | 2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109745372-B |
| titleOfInvention | Application of Jinqi hypoglycemic oral preparation in preparation of medicine for treating ulcerative colitis |
| abstract | The invention discloses application of a Jinqi hypoglycemic oral preparation in preparation of a medicine for treating ulcerative colitis, provides a new medicine selection for the ulcerative colitis, has no toxicity report in animal experiments and clinical application, has the characteristics of rich medicine sources, safety and no toxicity, can be further developed into an anti-inflammatory medicine, and has a clinical application prospect and a high economic utilization value. |
| priorityDate | 2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 181.